Skip to main content

Table 1 Characteristics of subjects of study

From: Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients

Characteristics n = 112
Age, years, mean (SD) 47.9 (12.47)
Male, n (%) 57 (50.9)
Tumor group, n (%)
 Head and neck 26 (23.2)
 Colorectal 20 (17.9)
 Musculoskeletal 8 (7.1)
 Breast 12 (10.7)
 Lung 12 (10.7)
 Genitourinary 8 (7.1)
 Gynecology 14 (12.5)
 Pancreatobiliary 10 (8.9)
 Thyroid 2 (1.8)
Stage (according to AJCC), n (%)
 I 3 (2.7)
 II 5 (4.5)
 III 17 (15.2)
 IV 87 (77.7)
Metastasis, n (%) 71(63.4)
SIRS, n (%) 56 (50)
Sepsis, n (%) 45 (40.2)
Severe sepsis, n (%) 10 (8.9)
Infection site, n (%)
 Pneumonia 24 (21.4)
 UTI 11 (9.8)
 Intra-abdominal 4 (3.5)
 Skin and soft tissue 8 (7.1)
 Blood 6 (5.3)
Leukocyte, /μL, median (min–max) 12,100 (1100–67,600)
CRP, mg/L, median (min–max) 23.5 (0.5–271.4)
PCT, ng/mL, median (min–max) 0.64 (0.03–921.4)
  1. AJCC American Joint Committee on Cancer, UTI urinary tract infection, CRP C-reactive protein, PCT procalcitonin